Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

PSX:ABOT Revenue

Abbott Laboratories (Pakistan) had revenue of 20.32B PKR in the quarter ending June 30, 2026, with 6.61% growth. This brings the company's revenue in the last twelve months to 77.02B, up 6.40% year-over-year. In the year 2025, Abbott Laboratories (Pakistan) had annual revenue of 75.40B with 10.59% growth.

• Revenue (ttm): 77.02B
• Revenue Growth: +6.40%
• P/S Ratio: 1.16
• Revenue / Employee: 55.81M
• Employees: 1,380
• Market Cap: 89.61B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	75.40B	7.22B	10.59%
Dec 31, 2024	68.18B	12.70B	22.90%
Dec 31, 2023	55.48B	6.22B	12.62%
Dec 31, 2022	49.26B	6.69B	15.71%
Dec 31, 2021	42.57B	7.29B	20.65%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 17, 2026

Data Sources Report a data error